Foundayo (Orforglipron) 14.5mg

Foundayo 14.5 mg contains orforglipron, an oral GLP-1 receptor agonist used for weight management in eligible adults with obesity or overweight accompanied by weight-related medical conditions. It is taken once daily alongside a reduced-calorie diet and increased physical activity, as prescribed by a healthcare professional.

Key Features & Specifications

• Active ingredient: Orforglipron
• Medicine class: GLP-1 receptor agonist
• Strength: 14.5 mg
• Form: Film-coated tablet
• Administration: Oral
• Frequency: Once daily
• Use: Weight management
• Pack size: 30 tablets
• Manufacturer: Eli Lilly
• Prescription: Yes